Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM )

35.15 -2.38 (-6.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Tandem Diabetes Care Appoints New Chair of Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Earns Great Place to Work Certification™
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Welcomes Two New Members to Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2021 Financial Results on February 22, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Expansion of Senior Leadership Team
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.